Introduction {#Sec1}
============

Osteoporosis is a progressive skeletal disease characterized by a decrease in bone mass and a disruption of bone architecture, leading to enhanced bone fragility and consequent increase in fracture risk especially in the elderly \[[@CR1]\]. This disease has become a highly prevalent health problem that affects millions of people around the world due to the increased longevity of the population, which results in it being a leading cause of disability and even premature death. Although generally regarded as a disease that predominantly affects women, it is estimated that approximately 30% of osteoporotic hip fractures occur in men. Due to the steady increase in the proportion of the elderly population and the rise in the incidence of fractures at earlier ages, an estimated doubling in the direct costs of such fractures to the healthcare services in the European Union (EU) is predicted by 2050 \[[@CR2]\].

Bone density in later life mainly depends on two key determinants: the peak bone mass achieved at skeletal maturity (during the third decade of life) and subsequent decline in bone strength and density occurring with age \[[@CR3]\]. The peak bone density is strongly determined by genetic factors (accounting for 60--80% of the variance) and other secondary factors such as nutrition, hormones, environment, and lifestyle \[[@CR4]\]. Calcium, potassium, magnesium, zinc, vitamin C, fiber, and fruits have been reported to induce changes in bone resorption and bone mass \[[@CR5]\].

Sodium ion (Na^+^) is the predominant cation of the extracellular fluid compartment. It induces the movement of water across cell membranes and largely dictates serum osmolality. Abnormality of sodium concentration due to disorders of water balance can lead to hyponatremia (defined as serum Na^+^ concentration less than 135 mM) or hypernatremia (more than 145 mM). The relationship between Na^+^ and bone density is therefore an evolving field of interest. While hyponatremia has been shown to stimulate osteoclast differentiation and resorptive activity \[[@CR6]\] and is thus highly associated with osteoporosis, increased fracture, and fall risks \[[@CR7]\], the relationship between hypernatremia and osteoclastogenesis is still open to discussion. Furthermore, although the recommended dietary intake (RDI) for Na^+^ lies between 920 and 2300 mg/day (40--100 mmol/day) \[[@CR8]\], there is an inclination for high-salt diets in our society and Na^+^ intake for adults estimated from 24-h urinary excretion to be higher than recommended \[[@CR8]\].

Previously published evidences from animal, clinical, and epidemiological studies have highlighted the contribution of high salt intake on osteoporosis development \[[@CR8], [@CR9]\]. Dietary sodium chloride (NaCl) supplementation in growing rats elevated the urinary calcium and phosphorus excretions without increasing calcium intestinal absorption, leading to imbalance and decreased accumulation of these minerals in the bone \[[@CR10]\]. Research involving postmenopausal women has indicated that after a restricted Na^+^ diet, a decrease in urinary Na^+^, calcium, and hydroxyproline/creatinine can be observed \[[@CR11]\]. On the other hand, evidence derived from humans and rats suggests that high Na^+^ intake is associated with increased urinary excretion of hydroxyproline \[[@CR12], [@CR13]\]. Devine et al. \[[@CR8]\] showed a negative correlation between urinary Na^+^ excretion and changes in bone mass over 2 years at the hip and ankle in postmenopausal women in a long-term observational study. In an extensive literature survey, MacGregor concluded that a reduction in salt intake could have a major beneficial role in bone density and therefore the prevention and treatment of osteoporosis \[[@CR14]\]. In an interventional study, Lin et al. \[[@CR15]\] demonstrated the beneficial effects on bone health caused by a reduction in Na^+^ intake. Harrington \[[@CR9]\], in an observational study, also concluded that higher salt intake leads to greater rates of bone resorption in postmenopausal women over a 4-week period.

Already, in 1937, Aub et al. \[[@CR16]\] observed that the elevation of NaCl intake increased the excretion of urine calcium. These findings have been confirmed in numerous animal experiments \[[@CR17]\] and in human studies \[[@CR18]\]. The extracellular ionized calcium levels are tightly regulated by a complex inter-relationship between gastrointestinal calcium absorption, renal excretion, and bone turnover \[[@CR19]\]. The average loss of calcium is 1 mmol calcium (40 mg) per 100 mmol (2290 mg) of Na^+^, and without any adaptive compensatory mechanisms, a daily loss of 40-mg calcium would deplete 10% of the skeleton within a decade \[[@CR20]\]. The mode of action, how NaCl influences bone resorption, is still controversial. Some studies indicated that the increase in urinary calcium excretion is associated with the enhanced production of serum parathyroid hormone (PTH). Goulding et al. found an increase in serum PTH due to high dietary salt loading \[[@CR21]\]. In one study conducted by Breslau \[[@CR22]\], young adults were also found to respond to Na^+^ supplementation with increases in urinary calcium and serum PTH. Loss of calcium usually triggers excretion of PTH from the parathyroid glands to compensate for it \[[@CR23]\]. Therefore, it has been hypothesized that PTH elevation is responsible for an elevated bone resorption in this setting. While an increased resorption of the bone after NaCl loading could indeed be demonstrated in patients, a significant elevation of PTH could not be measured \[[@CR8], [@CR20]\].

Therefore, we hypothesized that there may be a direct, cell-mediated effect of hypernatremia on bone resorption. To test this hypothesis in vitro, different hypernatremia conditions (normal, mild, moderate, and severe hypernatremia) were modeled by the external addition of NaCl solution to the cell culture media. The effect of these different hypernatremia conditions on mice and human osteoclast differentiation and function was studied.

Materials and methods {#Sec2}
=====================

Cell culture {#Sec3}
------------

Alpha minimum essential medium (α-MEM, Biochrom AG, Berlin, Germany) supplemented with 10% (*v*/*v*) fetal bovine serum (FBS; PAA Laboratories GmbH, Linz, Austria) was used for the preparation of hypernatremia cell culture media. According to the manufacturer's formulation, the basal concentration of Na^+^ is 142 mM. A 1-M NaCl (Sigma-Aldrich Chemie GmbH, Munich, Germany) solution was prepared in double-distilled water (ddH~2~O) and sterile-filtered before being diluted in the cell culture media (final concentrations 0, 2, 5, 10, 15, 25, and 50 mM). To characterize the culture media supplemented with different concentrations of NaCl, their pH and osmolality were determined via an ArgusX pH meter (Sentron Europe BV, Roden, Netherlands) and a Gonotec 030-D cryoscopic osmometer (Gonotec, Berlin, Germany), respectively. The results are presented in Table [1](#Tab1){ref-type="table"}. Based on the clinical practice guideline \[[@CR24]\], these concentrations were grouped in four categories: normal (135--145 mM; two NaCl treatment groups obtained by the external addition of 0 and 2 mM NaCl plus the basal 142 mM NaCl in α-MEM), mild (146--149 mM; one NaCl treatment group obtained by the external addition of 5 mM NaCl plus the basal 142 mM NaCl in α-MEM), moderate (150--169 mM; three NaCl treatment groups obtained by the external addition of 10, 15, and 25 mM NaCl plus the basal 142 mM NaCl in α-MEM), and severe hypernatremia (≥170 mM; one NaCl treatment group obtained by the external addition of 50 mM NaCl plus the basal 142 mM NaCl in α-MEM).Table 1Characterization of the culture media supplemented with different concentrations of NaClMediumpHOsmolality(mOsm/kg)a-MEM + 10%FBS7.85330a-MEM + 10%FBS + 2 mM NaCl7.83334a-MEM + 10%FBS + 5 mM NaCl7.84340a-MEM + 10%FBS + 10 mM NaCl7.85350a-MEM + 10%FBS + 15 mM NaCl7.85360a-MEM + 10%FBS + 25 mM NaCl7.85380a-MEM + 10%FBS + 50 mM NaCl7.83430

Bone marrow macrophages were flushed from 8-week-old mice, placed in a 6-cm^2^ dish in α-MEM (Biochrom AG, Berlin, Germany), and incubated for 3 h at 37 °C. After incubation, non-adherent cells were transferred in a 10-cm^2^ dish in the presence of 100 ng/mL of macrophage colony-stimulating factor (M-CSF; Peprotech Germany, Hamburg, Germany) for 2--4 days. Cells were then counted and seeded in a 96-well plate at a density of 15,000 cells/well in the medium containing 25 ng/mL of M-CSF (Peprotech Germany, Hamburg, Germany) and 100 ng/mL of receptor activator of nuclear factor κB ligand (RANKL; Peprotech Germany, Hamburg, Germany) as well as different concentrations of NaCl. The medium was refreshed every 2 days, and the cultures were kept for 11 days to obtain the mature mouse osteoclasts. The effect of different hypernatremia conditions on mouse osteoclast formation was evaluated through tartrate-resistant acid phosphatase (TRAP) activity at days 3, 4, 7, 9, and 11. TRAP staining was performed on day 4 while their resorption activity was investigated on day 11.

Buffy coats were obtained from healthy, anonymized donors at the Institute for Clinical Transfusion Medicine and Immunogenesis Ulm, Ulm, Germany, in a procedure approved by the review board of the German National Advisory Committee Blood at the Robert Koch Institute. All donors provided written consent that their cells can be used for medical, scientific, and pharmaceutical purposes. The peripheral blood mononuclear cells (PBMC) were freshly isolated from the buffy coats using a density gradient centrifugation technique. The monocytes were seeded in 48-well plates at a density of 2 × 10^6^ cells/mL and cultured in α-MEM (Biochrom AG, Berlin, Germany) containing 10% (*v*/*v*) FBS (PAA Laboratories GmbH, Linz, Austria) with 40 ng/mL RANKL and 20 ng/mL M-CSF in the presence of different concentrations of NaCl for 28 days to allow the complete differentiation and activation of mature osteoclasts. The more detailed protocol can be found in this publication \[[@CR25]\]. The impact of different hypernatremia conditions on osteoclastogenesis was measured via cell viability/proliferation and total protein content at days 3, 7, 14, 21, and 28. Furthermore, TRAP staining, calcitonin receptor (CTR) and cathepsin K (CK) immunocytochemistry, resorption activity assay, and real-time PCR were performed at day 28.

Cell metabolism assay {#Sec4}
---------------------

A water-soluble tetrazolium (WST-1) assay was selected to estimate the effects of various hypernatremia conditions on human osteoclast precursor and osteoclast-like cell (OCL) viabilities according to the manufacturer's instructions (Roche Diagnostic GmbH, Mannheim, Germany). After 3, 7, 14, 21, and 28 days, the cells were subsequently incubated with 50 μL/well of WST-1 dye solution at 37 °C for 2 h (biological replicates *n* = 3 wells). Culture medium containing 10% (*v*/*v*) of WST-1 without any cells was performed as blank. Following incubation, the supernatant was collected and pipetted into 96-well plates (three technical replicates) and the absorbance was immediately measured with a spectrophotometer at 450 nm (620-nm reference; Berthold Technologies GmbH, Bad Herrenalb, Germany).

Cell lysate preparation and determination of total protein content {#Sec5}
------------------------------------------------------------------

Total cellular proteins from human osteoclast cultures were extracted by using radioimmunoprecipitation assay (RIPA) lysis buffer (three biological replicates per NaCl concentration). In order to avoid any sample degradation, all solutions and materials used for this procedure were previously cooled. Cell layers were rinsed twice with PBS and then covered with RIPA lysis buffer which has been supplemented with protease inhibitor cocktail (Sigma-Aldrich Chemie GmbH, Munich, Germany) freshly before use. The adherent cells (including the combination of osteoclast precursors and OCLs) were harvested with a plastic cell scraper. Cell suspensions were subsequently transferred into pre-labeled 1.5-mL microcentrifuge tubes using pipette tips and then maintained on ice for 30 min for lysis with pipetting up and down every 10 min. Lysates were cleared of cell debris by centrifugation at 10,000×*g* for 10 min at 4 °C. The protein content was directly quantified with the BCA Protein Assay Kit (*n* = 2; Thermo Fisher Scientific, Bonn, Germany) according to the manufacturing method.

TRAP staining {#Sec6}
-------------

To confirm the generation of multinucleated OCLs, the expression of TRAP of the adherent cells on dentin slices was examined cytochemically after 4 days (for mouse) and 28 days (for human) (triplicates for each NaCl concentration). Adherent cells were rinsed with PBS and fixed with a TRAP fixation solution containing 3.7% formaldehyde (Carl Roth GmbH, Karlsruhe, Germany) and 0.2% Triton X-100 (Carl Roth GmbH, Karlsruhe, Germany) at room temperature (RT) for 5 min. Subsequently, fixed cells were dyed for acid phosphatase for 10--20 min at 37 °C with 0.1 mg/mL naphthol AS-MX phosphate (Sigma-Aldrich Chemie GmbH, Munich, Germany) and 0.5 mg/mL fast red-violet LB salt (Sigma-Aldrich Chemie GmbH, Munich, Germany) in the presence of 10 mM sodium tartrate (Carl Roth GmbH, Karlsruhe, Germany) and 40 mM sodium acetate (pH = 5; Carl Roth GmbH, Karlsruhe, Germany) which were freshly prepared before use. The staining solution was then removed and replaced with PBS. Red-stained TRAP-positive multinucleated cells that possessed three or more nuclei were counted as OCLs and photographed. The number of positive cells per square millimeter (at least five representative fields of view per condition) was computed based on the internal calibration of the microscope software (Zeiss).

CTR and CK immunocytochemistry {#Sec7}
------------------------------

The locations of CTR and CK in cultured human osteoclasts were detected by performing immunofluorescence staining and subsequent confocal laser scanning microscopy at day 28. PBS-rinsed cells were fixed by 3.7% formaldehyde (Carl Roth GmbH, Karlsruhe, Germany) for 10 min at RT. For CK staining, the fixed cells were subsequently permeabilized with a solution containing 0.1% Triton X-100 (Carl Roth GmbH, Karlsruhe, Germany) and 3% hydrogen peroxide (H~2~O~2~), 1:1 (*v*/*v*; Carl Roth GmbH, Karlsruhe, Germany). Blocking of non-specific binding was performed by immersing the cells in 10% (*w*/*v*) BSA (Carl Roth GmbH, Karlsruhe, Germany) in PBS for 1 h at 37 °C; thereafter, the cells were incubated with a polyclonal anti-CTR or polyclonal anti-CK primary IgG Ab (1:450 in PBS containing 1% (*w*/*v*) BSA; Santa Cruz Biotechnology, Inc., Heidelberg, Germany) for 1 h at 37 °C. After two 5-min PBS washing steps, fluorescence-labeled secondary antibodies (goat anti-rabbit IgG-Texas Red, Santa Cruz Biotechnology, Inc., Heidelberg, Germany) and Alexa Fluor568 goat anti-rabbit IgG (Life Technologies GmbH, Karlsruhe, Germany) for the anti-CTR and anti-CK primary antibodies, respectively, 1:450, in PBS containing 1% (*w*/*v*) BSA were applied and incubated for 1 h at 37 °C without light. Nuclei were counterstained by 1.5 μg/mL 4-6-diamidino-2 phenylindole (DAPI; Sigma-Aldrich Chemie GmbH, Munich, Germany). For quantification, the means of the percentages of CTR- and CK-positive cells (red-stained cells containing at least three nuclei) in the different culture conditions were further calculated (at least five representative fields of view per condition).

Resorption assay {#Sec8}
----------------

Osteoclast activities in both mouse and human culture systems were determined by a lacunar resorption assay in which the surface of the ivory slices (obtained from German customs, in accordance with the international laws for the protection of species; at least three chips per condition) was stained with a 1% toluidine blue (Carl Roth GmbH, Karlsruhe, Germany) solution (in ddH~2~O) at day 28. Two-dimensional (2D) and three-dimensional (3D) quantitative evaluations were then performed. Five fields of view of each dentin slice were randomly acquired. For the 2D evaluation, micrographs were acquired and the area of resorption pit was quantified using ImageJ analysis software. The means of the percentages of resorption area relative to the total area of the dentin surface in the different culture conditions were calculated (at least five representative fields of view per condition). Then, the surfaces of the dentin slices were analyzed with a Color 3D laser microscope (VK-9700; Keyence Corp, Japan) equipped with an optical laser unit and a scanning unit. Using VK Analyzer image analyzing software (version VK-X100/X200), 3D micrographs were reconstructed and the resorption volume was calculated (at least five representative fields of view per condition).

Reverse transcription RT-PCR {#Sec9}
----------------------------

RNA extractions were performed at day 28 using High Pure RNA Isolation Kit (Roche, Diagnostic GmbH, Mannheim, Germany) (three biological replicates per NaCl concentration). RNA concentrations (optical density---OD---at 260 nm) and purities (OD260/280) were measured by a NanoDrop 2000c (Thermo Scientific, Bonn, Germany) and converted into complementary DNA (cDNA) using Oligo-dT primers according to the manufacturer's instructions (QuantiTect Reverse Transcription Kit, Qiagen). The resultant cDNA was then subjected to PCR analysis (technical replicates) using SsoFast EvaGreen Supermixes, CFX96 real-time PCR detection system (both from Bio-Rad Laboratories GmbH, Munich, Germany), and the following primers (the gene-specific primers and reference genes): 5′-TCTCTCGGCGTTTAATTTGGG, 3′-AACCACCTCTTCACTGGTCAT for *CK*; 5′-CACCAAAGTCCTGGAGATCCCA, 3′-TTCTTCCTCCCGATGTCCGTCT for nuclear factor-activated T cells c1 (*NFATc1*); 5′-CTGGAAGCACGAATGACAGA, 3′-CCTTCTGCTTGCAAATAGGC for nuclear factor-κB 1 (*NFκB1*); 5′-CCCCAGCTTCATACCACCCTA, 3′-CCGGCATCTCAAGGTCACG for the osteoclast-associated receptor (*OSCAR*); 5′-GCTCAACAAGGACACAGTGTGC, 3′-CGCATCGGATTTCTCTGTCCCA for the receptor activator of nuclear factor κB (*RANK*); 5′-ATGGAAGGGTTTCCCCTCGT, 3′-CCAGTAATGGTCGCTATGGCT for spleen focus-forming virus (SFFV) proviral integration oncogene (*SPI1*); 5′-CTTCCTGGGCATGGAGTC, 3′-TGATCTTCATTGTGCTGGGT for *Actinβ*; 5′-TGCTGTCTCCATGTTTGATGTATCT, 3′-TCTCTGCTCCCCACCTCTAAGT for beta-2-microglobulin (*B2M*); 5′-GTCGGAGTCAACGGATTTG, 3′-TGGGTGGAATCATATTGGAA for glyceraldehyde-3-phosphate dehydrogenase (*GAPDH*), and 5′-AGTGGATGAGTTTCCGCTTT, 3′-ATATGGAAGCCATCTTTGCC for ribosomal protein L10 (*RPL10*). Reference genes (*actinß*, *B2M*, *GAPDH*, and *RPL10*) were carefully selected based on the geNorm algorithm method automatically calculated with the CFX Manager software. As the mispriming products and primer-dimers can complicate data interpretation, a melt curve analysis was performed to ensure the specificity of the PCR amplification. No-template control (NTC) melt curves are also conducted for evaluating specificity. Only the specific amplification (a single, tight peak on the dissociation curve for each well on the real-time PCR plate) was used for further analysis. Expression of the markers was normalized to the expression of the housekeeping genes, and results were analyzed with CFX Manager Software (Bio-Rad, Munich, Germany; version 3.1). Different gene expressions were statistically analyzed with a volcano plot in which the regulation threshold and *p* value were set to 2.00 and 0.05, respectively.

Statistical analysis {#Sec10}
--------------------

The entire experiment was carried out independently in two donors. One-way analysis of variance (ANOVA) was employed to assess the statistical significance of results via SigmaStat package (Systat software GmbH, Erkrath, Germany; version 11.0). The probability of a type I error was set to 5% (alpha = 0.05). The error bars represent standard deviation (SD). Linear regression analysis was performed with the change in TRAP-positive staining counts and 2D and 3D resorption activities as the dependent variables and supplemented NaCl concentration as the independent variable via SPSS Statistics version 20.

Results {#Sec11}
=======

Effects of increased NaCl concentrations on the differentiation and function of mouse osteoclasts {#Sec12}
-------------------------------------------------------------------------------------------------

The TRAP staining and resorption activities of mouse osteoclasts cultured in different hypernatremia conditions were investigated, and the results are shown in Fig. [1](#Fig1){ref-type="fig"}a, b, respectively. While the 50% increase in TRAP-positive cell numbers under moderate hypernatremia conditions was not statistically significant, resorptive activity was significantly higher in the moderate hypernatremia condition, consistent with the activating effect of NaCl at this concentration. Under the severe hypernatremia condition, the formation of TRAP-positive OCLs and their resorption activities were significantly reduced compared to the control, suggesting a potential toxic effect of very high concentrations of NaCl on murine osteoclasts.Fig. 1The effects of different concentrations of NaCl on mouse osteoclast differentiation and function were assessed by TRAP (**a**) and resorption activity (**b**). The effects of NaCl on human osteoclast precursors and OCL viability were assessed by WST-1 assay (**c**). For each time point, three wells of cell supernatant in each NaCl condition were conducted and measured with a spectrophotometer (technical triplicate). Total protein content isolated from human cells cultured with serial concentrations of NaCl at days 3, 7, 14, 21, and 28 (**d**). For each time point, total cellular proteins were isolated (triplicates per NaCl condition), and their content was quantified (two technical replicates). The respective statistical analyses are presented, and *symbols* represent the statistical significances between each group (*p* \< 0.05)

Cell metabolism assay {#Sec13}
---------------------

To study the influence of increased NaCl concentrations on the cell metabolism of human PBMC driven towards osteoclastogenesis, WST-1 assay was performed on days 3, 7, 14, 21, and 28 (Fig. [1](#Fig1){ref-type="fig"}c). A bell-shaped pattern was observable with the maximum at mild hypernatremia condition on day 3 (statistically significant difference detected between normal and mild/moderate conditions) and moderate hypernatremia condition on days 7, 14, 21, and 28 (statistically significant difference detected between normal and moderate conditions on day 14).

Cell lysate preparation and determination of total protein content {#Sec14}
------------------------------------------------------------------

The total protein contents of human cells cultured in the media supplemented with various hypernatremia conditions were measured after 3, 7, 14, 21, and 28 days of culture. Here, a decrease in the severe condition could be observed compared to other conditions (Fig. [1](#Fig1){ref-type="fig"}d). Significant differences were detected between the severe and normal conditions on day 3 and day 7. It is noteworthy that total protein contents were always the lowest in the case of severe hypernatremia at each time point.

TRAP staining {#Sec15}
-------------

The increasing of NaCl concentrations led to increasing numbers of human TRAP-positive osteoclasts (Fig. [2](#Fig2){ref-type="fig"}a). It was observed that the severe hypernatremia condition throughout the 28-day incubation significantly enhanced the formation of TRAP-positive OCLs (approximately fourfold increase when compared to the normal condition; Fig. [2](#Fig2){ref-type="fig"}b). Significant differences were also observable between the severe and mild/moderate conditions. Regression analysis showed a significant linear correlation of NaCl concentration and the number of TRAP-positive osteoclasts (*R* ^2^ = 0.9008; *p* \< 0.001) (Fig. [2](#Fig2){ref-type="fig"}c), suggesting a concentration-dependent effect.Fig. 2TRAP-stained osteoclasts on dentin slices at d28. **a** Micrographs of TRAP-positive staining of multinucleated cells (biological triplicates for each NaCl condition). The *scale bar* represents 100 μm. The number of TRAP-positive cells per square millimeter (at least five representative fields of view per condition) was recorded. **b** The respective statistical analyses are presented, and *symbols* represent the statistical significances between each group (*p* \< 0.05). **c** Regression analysis suggesting a linear relationship with *R* ^2^ = 0.901, *p* \< 0.001

CTR and CK immunocytochemistry {#Sec16}
------------------------------

As shown in Fig. [3](#Fig3){ref-type="fig"}a, b, elevation in NaCl concentration was found to increase the number of human CTR-positive cells and significant variation was detected between the severe and normal hypernatremia conditions (Fig. [3](#Fig3){ref-type="fig"}b). No fluorescent signal was detected in the negative controls. There was no statistically significant difference in the number of human CK-positive cells in the different treatment groups (Fig. [3](#Fig3){ref-type="fig"}c, d).Fig. 3Evidence of CTR and CK expressions in OCLs at day 28. **a** Micrographs of CTR staining (replicates per NaCl concentration). *Scale ba r*= 100 μm. **b** The means of the percentages of CTR-positive cells in the different culture conditions (at least five representative fields of view per condition). **c** Micrographs of CK staining (replicates per NaCl concentration). *Scale bar* = 100 μm. **d** The means of the percentages of CK-positive cells in the different culture conditions (at least five representative fields of view per condition). The respective statistical analyses are presented, and *symbols* indicate significant differences (*p* \< 0.05)

Resorption assay {#Sec17}
----------------

Similar to TRAP and CTR staining observations, an increased NaCl concentration was associated with a significant and linear increase in human osteoclastic resorption area (Fig. [4](#Fig4){ref-type="fig"}). Osteoclastic resorbing activity significantly increased at the severe hypernatremia condition compared to the normal/mild/moderate hypernatremia conditions (Fig. [4](#Fig4){ref-type="fig"}b). Regression analysis showed a significant linear correlation between NaCl concentration and resorption area (*R* ^2^ = 0.8917; *p* \< 0.001) (Fig. [4](#Fig4){ref-type="fig"}c).Fig. 42D resorption assay at day 28. **a** Micrographs of osteoclastic 2D resorption area (by toluidine blue staining; at least three chips per condition). *Scale bar* = 200 μm. **b** The osteoclastic resorption area was determined and presented as the means of the percentages of resorption area in at least five representative fields of view per condition. The respective statistical analyses are presented, and *symbols* indicate significant differences (*p* \< 0.05). **c** A positive linear correlation was confirmed in the regression analysis with *R* ^2^ = 0.892; *p* \< 0.001

The resorption activities of human osteoclasts were further analyzed by determining the resorption volume with a confocal laser scanning microscope. As shown in Fig. [5](#Fig5){ref-type="fig"}, both the shape and the size of individual resorption lacunae were highly variable in different hypernatremia conditions. The pits were smaller and shallower in normal/mild/moderate hypernatremia conditions compared to those in the severe hypernatremia condition. A significant increase in resorption activity relative to the control condition was found for all (mild/moderate/severe) high-NaCl conditions (Fig. [5](#Fig5){ref-type="fig"}). The volume of dentin excavated by osteoclasts in severe hypernatremia cultures was 3.5-fold higher compared to the control. Linear regression analysis showed a significant correlation between the resorption volume and the concentration of supplemented NaCl (*R* ^2^ = 0.9664; *p* \< 0.001) (Fig. [5](#Fig5){ref-type="fig"}c), suggesting a concentration-dependent effect.Fig. 5Effect of NaCl on bone-resorbing volume assessed by 3D analysis using confocal laser scanning microscopy. **a** Topographical views of resorption pits from randomly chosen sites in dentin slices (at least three chips per condition) produced by color 3D profile confocal laser microscope. *Color contours* represent the different depths of the resorption pits in the vertical direction (*black*, deep; *red*, shallow; μm). **b** Resorbed volume of the pits was determined using VK Analyzer image analyzing software (at least five representative fields of view per condition). The respective statistical analyses are presented, and *symbols* indicate significant differences (*p* \< 0.05). **c** The regression analysis indicates a linear correlation between the resorption volume and the concentration of supplemented NaCl with *R* ^2^ = 0.966, *p* \< 0.001 (color figure online)

RT-PCR {#Sec18}
------

After 28 days of culturing, RT-PCR was performed to investigate the molecular mechanism for the effect of NaCl on human osteoclastogenesis. As shown in Fig. [6](#Fig6){ref-type="fig"}, when cells were treated with increasing concentrations of NaCl, no significant difference was detected in the messenger RNA (mRNA) expressions for *CK*, *NFκB1*, *OSCAR*, and *RANK*. For the mRNA expression analyses of osteoclastic-specific genes *NFATc1* and *SPI1*, significant differences were detected between the normal and severe hypernatremia conditions.Fig. 6Determination of the mRNA expression of osteoclastic-specific genes in the cultures exposed to different hypernatremia conditions. Expression of markers is normalized to that of reference genes *actinß*, *B2M*, *GAPDH*, and *RPL10*. *Symbols* indicate significant differences between normal group and other hypernatremia conditions (*p* \< 0.05)

Discussion {#Sec19}
==========

We explored here the possibility of whether hypernatremia could have a direct influence on mouse and human osteoclasts via an in vitro osteoclastogenesis model. A direct, progressive, and PTH-independent osteoclastogenic effect of hypernatremic culture conditions was demonstrated.

In the present study, the influence of different hypernatremia culture conditions on mouse osteoclastogenesis was first investigated. An increase in TRAP activity and osteoclastic resorption activity was found with the increase in the concentration of supplemented NaCl (maximum at the moderate hypernatremia condition). In the human system, the results were even more consistent. The cell metabolism of PBMC-derived human osteoclast precursors and OCLs was then examined by WST-1 assay. We found an increase in metabolic activity of the cell combinations in the mild and moderate hypernatremia conditions. In the severe hypernatremia treatment, in comparison to the other groups including the control group, there was a strong downregulation at this concentration. This is consistent with a previous study in which C6 glioma cells from a rat were used and a reduction in the number of viable cells in a concentration-dependent manner was observed when exposed to high NaCl \[[@CR26]\]. While most of the studies involved acute application of NaCl for only a few hours, the response of HeLa (human cervical epithelial carcinoma) cells and primary mouse embryonic fibroblasts to prolonged exposure to high NaCl (18 and 10 days, respectively) was investigated. It was reported that the rate of proliferation of the NaCl-treated HeLa cells decreased gradually and the cells displayed signs of senescence while the appearance of cellular senescence in primary mouse embryonic fibroblasts was accelerated as well \[[@CR27]\]. Inorganic ions or compatible osmolytes as well as their resultant osmolarity seem to act on cell protein synthesis. A number of recent studies have shown that protein synthesis in cells exposed to the hypertonic osmolarity of the extracellular medium was profoundly inhibited. By raising the osmolarity of the culture medium to 0.4 Osm/L, Petronini et al. \[[@CR28]\] showed a maximal inhibition of 50--60% protein synthesis in chick embryo fibroblasts within 30 min of treatment. Consistently, transient impairment of the rate of protein synthesis also occurred in cultured endothelial cells \[[@CR29]\]. In our results presented here (Fig. [1](#Fig1){ref-type="fig"}d), the total protein content production in the severe hypernatremia group was also impaired at all the time points, suggesting an inhibition of cell metabolism and protein production in our culture system with high concentration of NaCl. Compared to day 3, there, however, still was a modest increase in both values detected at day 28, ruling out the general toxicity of a high concentration. Interestingly, even though there was a relatively lower overall cell activity in the severe group compared to the other groups at the same time point, we found more active osteoclasts there than in any other group suggesting diverging effects of increased NaCl concentrations on the mixed cell population at different stages of differentiation. A possible explanation for these data would be that increasing concentrations of NaCl favor osteoclast differentiation over proliferation of precursor cells, leading to a higher relative number of multinucleated osteoclasts. Indeed, when we analyzed the number of TRAP-positive multinucleated cells, a linear relationship was found between the number of osteoclast-like TRAP-positive multinuclear cells per square millimeter and the concentration of supplemented NaCl (Fig. [2](#Fig2){ref-type="fig"}; *R* ^2^ = 0.9008, *p* \< 0.001). This indicates an inductive effect of hypernatremic conditions on the formation of human bone-resorbing osteoclasts. Similar results were obtained for the CTR expression (Fig. [3](#Fig3){ref-type="fig"}).

While multinucleation and specific protein expression suggest the development of osteoclasts, their most important property is the resorption activity. We have performed 2D resorption area measurement and 3D resorption volume evaluation, which enable deeper analysis of the influence of a high concentration of NaCl on osteoclastic function. A well-fit linear correlation between the resorption capacity (in terms of resorption area and volume) and the NaCl concentration was found with *R* ^2^ = 0.8917 (Fig. [4](#Fig4){ref-type="fig"}) and 0.9664, respectively (Fig. [5](#Fig5){ref-type="fig"}), suggesting a direct, activating effect of hypernatremic conditions on the function of human osteoclasts. In order to further study the mechanism of the significantly enhanced bone resorption in different hypernatremia conditions, we determined the relative resorption of a single osteoclast by normalizing the percentage of the resorbed area by the number of TRAP-positive cells. We found a decrease in single-cell resorption in hypernatremia condition (data not shown), suggesting that the observed effect is mainly due to the increased numbers of osteoclasts and not the increased resorption activity by an individual cell. However, as this is an endpoint analysis (day 28), it is difficult to distinguish the effects of various hypernatremia conditions on different phases in a mixed cell population. To rule out the effect on a single osteoclast, additional experiments with freshly reseeded osteoclasts under different NaCl conditions would be necessary. Our results, however, clearly indicated an increase in NaCl-induced bone resorption in a direct, cell-mediated fashion without regulation by PTH.

To elucidate the molecular mechanism of NaCl's stimulatory effects on osteoclast formation and function, we analyzed the mRNA levels of the genes during osteoclastogenesis in the exposure to different hypernatremia conditions. Among the many genes related to osteoclast differentiation, the mRNA levels of *NFATc1* and *SPI1*, master transcription factors for osteoclastogenesis, were significantly increased (Fig. [6](#Fig6){ref-type="fig"}). It is widely accepted that M-CSF and RANKL released by osteoblasts are the two key cytokines that are essential and sufficient for the differentiation of osteoclasts from the monocyte/macrophage lineage. The binding of M-CSF to its receptor (colony-stimulating factor 1 receptor or c-Fms) will activate the survival and proliferation of osteoclast precursor cells and the RANK expression, evoking efficient response to the RANKL-RANK signaling pathways. The RANKL-RANK interaction will in turn trigger a sequence of events that leads to the activation of various downstream transcription factors, such as NFκB and the expression of the master regulators for osteoclast differentiation, i.e., *NFATc1* and *SPI1* \[[@CR30]\]. In particular, *NFATc1* is considered to be the transcription factor that is most strongly induced by RANKL \[[@CR31]\]. Interestingly, we did not see a parallel increase in *CK*, *NFκB1*, *OSCAR*, and *RANK* in our analyses. This might be caused by the poor correlation between gene expression and protein levels. Vogel and Marcotte \[[@CR32]\] have reviewed that since there are many processes between cellular transcription and translation, changes in gene expression level are frequently not reflected at the protein level (the correlation can be as little as 40%). The transcriptional level data in this study can only suggest whether or not the protein is present. However, it has been highly confirmed that there is an increase both in the TRAP-positive OCL formation and in the 2D and 3D resorptive data in the culture with the highest concentration of NaCl. While the present study demonstrates a direct relationship between hypernatremia and mouse/human osteoclastic resorption activity, it does not completely exclude the possibility that factors associated with hypernatremia, such as a higher extracellular osmolality, can play a role on osteoclastogenesis. It has been demonstrated that changes in extracellular osmolality might induce cell swelling which activates stretch- and swelling-activated cation channels. The activation of the calcium channels thus leads to the increase in calcium influx and intracellular calcium. This might influence osteoclastic behavior through promoting osteoclast apoptosis and inhibiting osteoclastic bone resorption \[[@CR33]\]. However, in our previous work, we did not observe the effect of changes in osmolality through Mg^2+^ \[[@CR34]\]. It suggests that it is NaCl rather than the resultant high extracellular osmolality that induces osteoclastogenesis. In other words, if the negative role of the osmolality exists, it might be abolished by the strong effects of NaCl on osteoclastogenesis. Using cellular and molecular approaches, Barsony et al. \[[@CR6]\] suggested as well that it is the medium Na^+^ level rather than the resultant osmolality that changed osteoclast formation and resorption activity in experiments with a low concentration of NaCl. Similar mechanisms could also act at higher concentrations of Na^+^. An important question is how osteoclasts sense increased extracellular Na^+^ concentration. Voltage-gated Na channels were suggested to function as Na sensors in the bone \[[@CR35]\]. Interestingly, assays on murine preosteoclastic RAW 264.7 cells and on primary marrow monocytes both suggested that hyponatremia could be associated with osteoporosis \[[@CR6]\]. However, there is inconclusive evidence on the effect of hyponatremia on the development of osteoporosis in human patients \[[@CR36]\]. Hyponatremia seems to directly contribute to increased bone resorption through decreased cellular uptake of ascorbic acid and the induction of oxidative stress \[[@CR37]\]. Furthermore, it has been investigated that hyponatremic patients have elevated circulating levels of arginine vasopressin (AVP) and that this is at least in part responsible for the phenotype \[[@CR38]\]. As AVP is also increased with dehydration in hyperosmolar hypernatremia, it may influence bone remodeling with a similar mode of action.

Nevertheless, hypernatremia may lead to the activation of osteoclasts through another completely different pathway. One possible route may be an exchange of calcium and sodium through sodium/calcium exchanger (NCX) family like NCX1 which has been revealed to act as a regulator of osteoclast-mediated bone resorption \[[@CR39]\]. An increased extracellular level of sodium might lead to the depletion of intracellular calcium through these exchangers and consequently to the increase of their resorptive function. In the present study, since we were mainly interested in the human diseases, the effect of hypernatremia on osteoclastogenesis was therefore primarily investigated in a human cell culture system. Instead of a PTH-dependent role of high salt intake on bone resorption, a direct, cell-mediated effect of hypernatremic conditions on human osteoclastogenesis was shown. In order to test whether the regulation pattern of osteoclastogenesis by increased concentrations of NaCl also applies to other species, the effects of different hypernatremia conditions on osteoclastogenesis derived from murine bone marrow macrophages were also investigated as an alternative system. Also, in the murine cells, we found an increased resorption area at moderately elevated concentrations of NaCl, suggesting a conserved mechanism. At severely high concentrations of Na, the mouse cells were overall impaired, while the human cells were further stimulated. The laboratory mouse provides an attractive mammalian model due to its ease of genetic manipulation. However, Rangarajan and Weinberg reviewed that there are fundamental differences between the two species \[[@CR40]\]. Furthermore, differences between human and mouse embryonic stem cells were reported to be species-specific rather than arising from differences in culturing conditions \[[@CR41]\].

Severe hypernatremia has been described in various case reports, as high as a serum Na^+^ concentration of 185 \[[@CR42]\], 195 \[[@CR43]\], or even 255 mM \[[@CR44]\]. In those cases, compared with other multiple pathologies (like metabolic acidosis and severe neurological impairment) caused by an extremely high Na^+^ concentration, the increase in the generation of osteoclast would probably be a minor concern. However, our finding that bone resorption has already increased significantly at medium NaCl concentrations suggests that it may be important for bone physiology.

Conclusion {#Sec20}
==========

Taken together, our data suggests that mouse/human osteoclastic differentiation and function are directly and positively regulated by NaCl concentrations over the physiologic 142 mM. Therefore, the reported increased bone resorption after diets rich in NaCl and in diseases with changes in water balance leading to high serum Na^+^ may not only be secondary to the urinary loss of calcium but may also be due to a direct, cell-mediated effect of increased Na^+^ concentration on osteoclasts. This may be especially important, as dehydration also leads to increased NaCl concentration in the body and therefore around bone cells. Especially old people are known to lose the appropriate thirst to balance their water intake. Furthermore, if NaCl directly increases osteoclastic resorption, patients with a dysbalance of the NaCl metabolism might show stronger response to anti-resorptive treatment.

These findings may help to explain clinical findings on bone metabolism in patients with increased serum concentrations of NaCl.
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